Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Norihisa Takasugi"'
Autor:
Norihisa Takasugi
Publikováno v:
Nihon Naika Gakkai Zasshi. 101:3553-3556
Autor:
Kenichi Arita, Junko Tsuyama, Tsuyoshi Kataoka, Kazuya Miyoshi, Kenji Higaki, Norihisa Takasugi, Yoshimi Hidani, Shigeru Murakami, Kouki Inai
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 20:90-96
Publikováno v:
Therapeutic Apheresis and Dialysis. 14:577-582
There have been few long-term prospective studies investigating the effect of cinacalcet on secondary hyperparathyroidism with or without nodular hyperplasia. We examined whether the effect of cinacalcet on secondary hyperparathyroidism differed betw
Autor:
Norihisa Takasugi, Noriaki Yorioka, Ayumu Nakashima, Juan Jesus Carrero, Toshinori Ueno, Yoshihiko Taniguchi, Takayuki Hirai, Abdul Rashid Qureshi, Bengt Lindholm
Publikováno v:
Osteoporosis International. 22:1695-1701
A high circulating osteoprotegerin (OPG) level may be a risk factor for vascular calcification and mortality in hemodialysis patients. OPG and pulse wave velocity (PWV) were measured at baseline in 151 normoalbuminemic, long-term (3 years) Japanese h
Autor:
Koji Usui, Norihisa Takasugi, Noriaki Yorioka, Nobuoki Kohno, Kenichiro Shigemoto, Ayumu Nakashima, Toru Kawai, Kei Kiribayashi, Naoki Hamaguchi, Mariko Ochiai
Publikováno v:
Nephron Clinical Practice. 117:c15-c19
Background: A low level of intact parathyroid hormone (PTH) is an indicator of adynamic bone disease in hemodialysis patients, and is associated with a significant increase of all-cause mortality. Thus, effective treatment for adynamic bone disease i
Autor:
Norihisa Takasugi, Kei Kiribayashi, Nobuoki Kohno, Junko Tanaka, A. Kawai, Ayumu Nakashima, Naoko Sugiya, Noriaki Yorioka
Publikováno v:
Osteoporosis International. 22:1573-1579
Postmenopausal hemodialysis patients are at risk of complications related to renal mineral and bone disorder, and postmenopausal osteoporosis. In 112 postmenopausal hemodialysis patients, free estrogen index was positively correlated with bone minera
Autor:
Takao Masaki, Norihisa Takasugi, Nobuoki Kohno, Noriaki Yorioka, Satoshi Okumoto, Ayumu Nakashima, Takahiko Ogawa, Yoshihiko Taniguchi, Takafumi Ito
Publikováno v:
Therapeutic Apheresis and Dialysis. 13:205-212
Mortality from cardiovascular or cerebrovascular disease due to atherosclerosis is increased in patients on chronic hemodialysis. Monocyte chemoattractant protein-1 and its receptor, C-C chemokine receptor 2, play an important role in recruiting mono
Publikováno v:
Nephron Clinical Practice. 111:c81-c86
Background/Aims: Darbepoetin alpha is an erythropoietic agent with a 3-fold longer elimination half-life than epoetin. The recommended conversion ratio from epoetin to darbepoetin alpha is 1:200 (1 μg of darbepoetin alpha = 200 IU of epoetin), but s
Autor:
Satoe Naraki, Norihisa Takasugi, Shigehiro Doi, Michihiro Yamahira, Ayumu Nakashima, Noriaki Yorioka, Toshifumi Ohmoto, Takao Masaki, Satoshi Ogata, Takafumi Ito
Publikováno v:
Clinical and Experimental Nephrology. 10:210-215
It is important to observe the flow pattern of dialysate when evaluating dialyzer function and developing the most appropriate design. We investigated dialysate flow through two polysulfone membrane dialyzers (TS-UL [Toray Medical] and APS-S [Asahi M
Autor:
Kenichiro Shigemoto, Noriaki Yorioka, Ayumu Nakashima, Nobuoki Kohno, Shigehiro Doi, Norihisa Takasugi
Publikováno v:
Osteoporosis International. 17:841-846
Osteoprotegerin is a soluble glycoprotein that belongs to the tumor-necrosis-factor receptor superfamily. In vitro, osteoprotegerin blocks osteoclastogenesis in a dose-dependent manner. The serum osteoprotegerin level shows a positive correlation wit